(NASDAQ: MIRA) Mira Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 105.06%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 54.34%.
Mira Pharmaceuticals's earnings in 2025 is -$7,765,054.On average, 1 Wall Street analyst forecast MIRA's earnings for 2025 to be -$8,390,499, with the lowest MIRA earnings forecast at -$8,390,499, and the highest MIRA earnings forecast at -$8,390,499.
In 2026, MIRA is forecast to generate -$7,818,419 in earnings, with the lowest earnings forecast at -$7,818,419 and the highest earnings forecast at -$7,818,419.